Related Experiment Videos
Eosinophil activation markers in induced sputum in asthmatics
1Department of Internal Medicine, Chonnam University Medical School, Chonnam University, Kwangju, Korea.
The Korean Journal of Internal Medicine
|March 14, 2000
Summary
Eosinophil activation markers in sputum, including eosinophil cationic protein (ECP) and interleukin-5 (IL-5), correlate with asthma severity. Induced sputum analysis is a valuable tool for assessing airway inflammation in asthma patients.
Area of Science:
- Pulmonary Medicine
- Allergy and Immunology
- Respiratory Research
Background:
- Eosinophils are key players in asthmatic airway inflammation.
- Assessing eosinophil activation in sputum could provide insights into clinical status.
Purpose of the Study:
- To determine if eosinophil activation markers in induced sputum correlate with clinical status in asthma.
- To investigate the utility of induced sputum analysis for measuring airway inflammation in asthma.
Main Methods:
- Induced sputum was collected from 25 asthmatics and 10 controls using hypertonic saline.
- Sputum was analyzed for cell counts, eosinophil cationic protein (ECP) via fluoroimmunoassay, and interleukin-5 (IL-5) via ELISA.
- Clinical severity and FEV1 were measured.
Main Results:
- Asthmatics showed significantly higher sputum eosinophils and ECP levels compared to controls.
- Interleukin-5 (IL-5) was detected more frequently in asthmatics.
- Higher eosinophil proportions and ECP/IL-5 levels were observed in moderate to severe asthmatics, correlating with reduced FEV1.
Conclusions:
- Eosinophil activation markers (ECP, IL-5) in induced sputum are closely linked to clinical status in asthma.
- Induced sputum analysis is a useful method for assessing airway inflammation in asthma.
- These markers may aid in monitoring asthma severity and guiding treatment.